G. Bhusnure Omprakash 1*, V. Poulkar Madhuri 2, B. Gholve Sachin 2
- Department of Quality Assurance, Channabasweshwar Pharmacy, College (Degree) Kava Road, Basweshwar Chowk, Latur, Maharashtra-413512, India
- Department of Quality Assurance, Channabasweshwar Pharmacy College (Degree), Kava Road, Basweshwar Chowk, Latur, Maharashtra-413512, India
Abstract
A simple, specific and economic UV spectrophotometric method has been developed using as a solvent methanol:water (80:20) to determine the Nabumetone content in bulk and pharmaceutical dosage formulations. The quantitative determination of the drug has been carried out at a predetermined ?max of 270nm, it was proved linier in the range 2-12 ?g/mL and exhibited good correlation coefficient (R2=0.997) and excellent mean recovery (98-100.09%). The method was validated statically and by recovery studies for linearity, precision, repeatability and reproducibility as per ICH guideline. The obtained results proved that the method can be employed for the routine analysis of Nabumetone in bulk as well as in the commercial formulations.� �
References
- Friedel, HA, Todd PA. Drugs 1988; 35:504-524.
- Friedel HA, Langtry HD, Buckley. Drugs 1993; 45:131-136.
- Davies NM. Clin. Pharmakokinet 1997; 33:403-416.
- Rao YS, Chowdary KP, Seshagiri RJ. A Colorimetric Assay Method for Nabumetone. Indian J Pharm Sci. 2003; 65:206-207.
- European Pharmacopoeia, 6th edn. (Suppl. 6.2), Council of Europe, Strasbourg, France, 2007.
- British Pharmacopoeia, Directorate for the quality of medicine & Healthcare of the council of Europe (EDQM), 2007, 2: 1430.
- United states Pharmacopoeia, USP 30/NF 25, US Pharmacopoeial Convention, Inc., Rockville, 2007; Asian Edition, 2693.
- Reddy GK, Rao JV, Varma RLB, Sankar DG. Indian Drugs. 2001; 38: 336.
- Kobylinska K., Barlinska M, Kobylinska. M. Analysis of Nabumetone in human plasma by HPLC. Application to single dose pharmacokinetic studies. J. Pharm. Biomed. Anal. 2003; 33: 323 � 328.
- Mikami E., Goto T., Ohno T., Matsumoto H., Nishida M. Simultaneous analysis of Naproxen, Nabumetone and its major metabolite 6methoxy-2naphthylacetic acid in pharmaceuticals and human urine by high-performance liquid chromatography. J. Pharm. Biomed. Anal. 2000; 23: 917�925.
- ICH harmonized tripartite guideline, Q2(R1), Validation of analytical procedures: text and methodology,� in International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use, 2005.
- Blessy.M., Development of forced degradation and stability indicating studies of drugs-A review, Journal of Pharmaceutical Analysis, 2014; 4(3): 159� 165.
- Guidance for industry, analytical procedures and methods validation for drugs and biologics. Draft Guidance, U.S. Department of Health and Human Services, Food and Drug Administration (FDA), Center for Drug Evaluation and Research (CDER), Center for Biologics Evaluation and Research (CBER), CMC, 2014.
- Shabir GA, John LW, Arain SA, Bradshaw TK. Evaluation and application of best practice in analytical method validation. J of Liquid Chroma and Related Tech, 2007; 30(3): 311�333.
- Hanaa Saleh, Gamal H. Ragab, Mohammed A. Othman, Stability indicating HPLC method development and validation for determination of daclatasvir in pure and tablets dosage forms, Indo American Journal of Pharmaceutical Sciences, 2016; 3 (12): 1565-1572.
- Mark Green J. A practical guide to analytical method validation. Analytical Chemistry, 1996; 68(9): 305A�309A.
- USP 37, NF 32. Validation of compendial methods, chapter 1225. The United States Pharmacopeial Convention, Rockville, Md, USA, 2014.
